ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 258 filers reported holding ACCELERON PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $67,638,000 | +456.8% | 601,066 | +371.4% | 0.85% | +397.1% |
| Q2 2020 | $12,147,000 | -47.5% | 127,500 | -50.5% | 0.17% | -56.0% |
| Q1 2020 | $23,146,000 | +306.1% | 257,549 | +139.6% | 0.39% | +380.2% |
| Q4 2019 | $5,700,000 | -2.3% | 107,500 | -37.4% | 0.08% | +17.4% |
| Q2 2014 | $5,836,000 | -90.9% | 171,800 | -90.8% | 0.07% | -91.3% |
| Q1 2014 | $64,439,000 | -23.2% | 1,867,800 | -11.8% | 0.79% | -35.7% |
| Q4 2013 | $83,859,000 | – | 2,117,648 | – | 1.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |